key: cord-0743795-ggmok9gz
authors: Gillam, Marianne H; Roughead, Elizabeth; Tavella, Rosanna; Dodd, Tom; Beltrame, John; Ryan, Richard; O'Loughlin, Peter
title: The impact of COVID‐19 restrictions on pathology service utilisation
date: 2021-08-25
journal: Intern Med J
DOI: 10.1111/imj.15501
sha: 94b6c0cdedd501cf73d81ca971ad8b5013180c9d
doc_id: 743795
cord_uid: ggmok9gz

BACKGROUND: Isolation and social distancing restrictions due to COVID‐19 have the potential to impact access to health care services. AIMS: To assess the use of pathology services during the COVID‐19 pandemic initial restrictions. METHODS: Repeated cross‐sectional study of pathology tests utilisation during a baseline time period early in 2020 compared to pre‐lockdown and lockdown due to COVID‐19 in South Australia. The outcome measure was change in number of pathology tests compared to baseline period, particularly change in the number of troponin tests to determine potential impacts of lockdown on urgent care presentations. RESULTS: In the community setting the ratio of number of pathology tests pre‐lockdown and post‐lockdown vs. baseline period decreased from 1.02 to 0.53 respectively. The exception was microbiology molecular tests, where the number of tests was more than 3 times higher in the lockdown period. The number of troponin tests in emergency departments decreased in the lockdown period compared to the baseline time period, however, there was no evidence of an association between tests result (positive vs negative) and time period (OR 1.09 95% CI 0.97–1.22). There was an inverse relationship between age and time period (OR 0.995, 95%CI 0.993–0.997), indicating that fewer troponin tests were conducted in older people during the lockdown compared to the baseline period. CONCLUSION: COVID‐19 restrictions had a significant impact on the use of pathology testing in both urgent and non‐urgent care settings. Further studies are needed to investigate the effect on health outcomes as a result of the COVID‐19 restrictions. This article is protected by copyright. All rights reserved.

Isolation and social distancing restrictions due to COVID-19 have the potential to affect access to health care. People may choose not to visit their doctor either for monitoring existing health conditions or for new conditions due to fear of catching the virus or burdening the health system [1] [2] [3] .

Consequently, there may be a build-up of undiagnosed health conditions in the community resulting in unnecessary morbidity and mortality 4, 5 . As an example of the impact of the COVID-19 pandemic on hospitalisations for a life threatening condition, a decrease in incidence of hospitalisation for acute myocardial infarction has been reported in the US and Italy 4, 6 . Conversely during March 2020 there was an increase in Google searches for 'chest pain' which were correlated with the increase in number of COVID-19 cases in the US, possibly due to patients self-triaging at home 7 . Another example on impact on urgent care service utilisation is the reported decrease in number of aeromedical retrievals undertaken in Australia during the lockdown period 8 . However, there are also reports indicating a potential reduction of unnecessary care. A systematic review of health care utilization during the COVID-19 pandemic compared to previous years found a greater reduction in users of healthcare services with mild illness compared to more severe illness 9 .

Changes in pathology testing can be considered a sentinel marker for changes in health service utilisation in general, thus mapping pathology test activity can provide information on the impact of COVID-19 restrictions on health service utilisation. A setting such as South Australia with very low COVID-19 incidence, but strong restrictive measures, is well placed to investigate the impact on initial COVID-19 restriction per se. Furthermore, mapping the impact on test type and the healthcare settings that have been affected can highlight issues and inform the need for subsequent targeted interventions.

In South Australia, restrictions on social movements were introduced in March 2020 concurrent with introduction of national restrictions. Restrictions consisted of a ban on social gatherings (e.g. public gatherings with more than 500 people were cancelled on 15 March), social distancing rules (put in place 21 March), travel restrictions, quarantine requirements and lockdown of public places (e.g. restaurants and pubs closed 21 March). The objective of the study was to assess the impact of the first four weeks of COVID-19 restrictions on the utilisation of pathology testing services in South Australia compared to baseline periods in the same year and in the previous year (2019).

This was a retrospective repeated cross-sectional study of the number of pathology tests performed during an 11-week time period (week 5 to 15 of 2020; i.e. 27 January to 12 April). We chose weeks 5 to 8 (27 January -23 February 2020) as the reference baseline period, weeks 9 to 11 (24 February - 

The SA Pathology service is the sole provider of public hospital pathology testing in South Australia and undertakes 35% of all community pathology tests requested by GPs and specialists with feed-in from every region of South Australia. Hence the dataset constitutes all public hospital (including emergency department) pathology tests and approximately one-third of community tests.

In addition, data from patients who had angiogram for acute myocardial infarction (AMI), sourced from 14 hospitals in South Australia, were examined.

The study cohort consisted of people in South Australia who had pathology tests in the community and emergency departments (ED) during the study period. Community tests included tests requested by GPs and physicians outside the hospital setting and ED tests included tests conducted in public hospital EDs. Troponin test impact analysis was limited to troponin requests from public hospital EDs

The SA Pathology tests were examined by the following discipline or sub-discipline groups:

anatomical pathology (AP) specimen, blood bank, coagulation, endocrinology, general chemistry, haematology, immunology, non-molecular microbiology, molecular microbiology and serology. To determine potential negative effects of COVID-19 related restrictions on a health condition requiring urgent care such as acute coronary syndrome (ACS), we investigated troponin test (belonging to general chemistry) requests in EDs for adults 18 to 100 years old.

To assess the changes in number of pathology tests conducted in the community and in public hospital EDs, we compared the weekly number of SA Pathology tests in pre-lockdown and lockdown (weeks 9 to 15) to average weekly number of tests in baseline (week 5 to 8). For each discipline of SA Pathology tests ordered in the community, the ratio of number of tests in the 4 week baseline period was compared to the number of tests in the 4 weeks lockdown (i.e. week 12 to 15) and calculated for 2019 and 2020.

For the SA Pathology troponin tests, any tests recorded from a person within one day of the first test were counted as one test. The test was considered as positive if any of the tests taken within the time frame were equal to or greater than 30 ng/L. Logistic regression was undertaken to examine the relationship between time periods when the troponin tests were performed (lockdown vs baseline) and age of patients and troponin test result.

For patients undergoing angiogram for AMI in public hospitals the incidence rate (IR) per 100,000 person-weeks were calculated for two periods in 2020 (the baseline and lockdown period) and for the first four months of 2019 (1 January to 28 April).

We chose 0.05 as the alpha level for statistical significance. Stata/IC 16 was used for the analysis.

Ethics approval for the study was obtained from Central Adelaide Local Health Network and University of South Australia Human Research Ethics Committees.

The number of SA Pathology tests per week in pre-lockdown and in lockdown compared to the average number of weekly tests in the baseline period is presented in Figures 1 and 2 The IR of angiogram for AMI in public hospitals did not decrease over the two periods in 2020.

During baseline in 2020 there were 142 angiograms for AMI consistent with an IR of 2.64 (95% CI 2.20-3.07) per 100,000 person weeks compared to 138 angiograms during lockdown with IR of 2.56 (95% CI 2.14-2.99). The IR in the beginning of 2019 was similar to the two periods in 2020, over the first four months there were 516 events corresponding to an IR of 2.26 (95%CI 2.03-2.48).

There was a decrease in the number of pathology tests requested in 2020 during the first South Australian COVID-19 lockdown both from the community and from EDs compared to earlier in the year. The exception was microbiology molecular tests, which include virology PCR testing, where the number of tests was higher in both 2019 and 2020 in week 12-15 compared to week 5-8. The reason for this is likely due to the emergence of seasonal influenza during this period in 2019 10 and COVID-19 in 2020.

The number of troponin tests, as an indicator of urgent care, decreased in the lockdown period compared to the baseline period, however, there was no evidence for an association between tests result (positive vs negative) and lockdown. This may suggest either that there were fewer occurrences of ACS or that people with ACS did not present to EDs during the lockdown period. The latter theory is supported by a report that during the peak COVID-19 outbreak in New York in the first half of 2020 there was a doubling of out of hospital deaths concurrent with a halving of ACS hospitalisations 11 . However, it has also been suggested that a more sedentary lifestyle, and less smoking may have led to a decrease in people who suffer ACS 12 . Our results showed an inverse association between patient age and numbers of troponin tests in lockdown which may suggest that possible avoidance behaviour was more pronounced in older age groups who are at increased risk of suffering severe effects associated with COVID-19. The finding is supported by a nationwide Danish study which found that the largest decrease in ACS admissions was in those older than 60 years of age 13 . This is of concern as the incidence of ACS increases with age and if not treated promptly has a poor prognosis and is associated with increased cost to the health system 14 . However, although not representing the exact matching cohort, the IR of coronary angiograms undertaken for AMI across 14 public hospitals were similar over the baseline and lockdown period and to 2019, which could indicate that the rate of AMI did not change in those who were eligible for coronary angiogram. The reason for the discrepancy may be that the decrease in ED presentations for troponin tests consisted of elderly people that were too frail to undergo angiogram, e.g. people living in nursing homes where the potential risk associated with COVID-19 were considered too high to present at an ED.

Additionally, the discrepancy could be explained by less presentations with non-MI related chest pain with positive troponin, e.g. pericarditis, which did not require angiograms, hence all patients with AMI may have presented to hospital and received appropriate care.

The main limitation of this research is that although SA Pathology is the largest provider of pathology services, not all pathology tests conducted in the community in South Australia are included.

However, because SA Pathology covers a broad range of services, it is likely that the sample is representative of the pathology tests conducted in South Australia during the period. Furthermore, by comparing number of tests conducted in the lockdown to baseline average number as well as number of tests in the previous year, the relative change could be assessed. The percentage of positive troponin tests is expected to be within 5-20% ACS of ED chest pain presentations 14 , but it was not possible to establish the proportion of patients with positive troponin tests who had ACS, because the pathology tests were not linked to ED diagnoses.

During COVID-19 pandemic there have been reports about several conditions with a decrease in health care presentations. A study examining hospital presentation for stroke in Hong Kong suggested that there was reluctance to seek treatment for stroke symptoms during the pandemic 15 .

Our findings are interesting because South Australia was one of the locations in the world with the lowest incidence of COVID-19 during the early phases of the pandemic. The first cases were reported late February, and by end of week 15 there had been 430 cases (see Figures 1 and 2) . Hence in South Australia the health care system was not overburdened by COVID-19 cases during the study period and as such did not represent a barrier to patient presentations at ED. The behaviour of not seeking treatment for urgent care conditions needs to be addressed in preparation for further possible COVID-19 restrictions and other pandemics. Conversely, overuse of pathology testing is a known issue in health care services and leads to increased risk of harm to patients and contributes to overspending in the health system 16 

This article is protected by copyright. All rights reserved.

Fewer presentations to metropolitan emergency departments during the COVID-19 pandemic

Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

Disruptions in preventive care: Mammograms during the COVID-19 pandemic

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction

Internet search volume for chest pain during the COVID-19 pandemic

Aeromedical retrieval diagnostic trends during a period of Coronavirus 2019 lockdown

Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review

Influenza in South Australia: number of clinical and laboratory diagnoses per week

Out-of-Hospital Cardiac Arrest and Acute Coronary Syndrome Hospitalizations During the COVID-19 Surge

Incidence of acute coronary syndrome during national lock-down: insights from nationwide data during the coronavirus disease 2019 (COVID-19) pandemic. Am Heart

CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

Delays in Stroke Onset to Hospital Arrival Time During COVID-19

Evaluation and cost estimation of laboratory test overuse in 43 commonly ordered parameters through a Computerized Clinical Decision Support System (CCDSS) in a large university hospital

The landscape of inappropriate laboratory testing: a 15-year meta-analysis